Welcome - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Premium Company Profile Celgene' returned 2 results - Page 1 of 1   Sort by    Date Published ASC Date Published DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Idiopathic Pulmonary Fibrosis (IPF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Dec 2011, Pages: 85 Assessment 7.1 Key Events Impacting the Future Market 7.2 IPF Therapeutics - Implications for Future Market Competition 8 IPF Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8 Acute Ischemic Stroke (AIS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018   GlobalData, Sep 2011, Pages: 89 Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 H Lundbeck A/S 8.2.2 D-Pharm, Ltd. 8.2.3 Aldagen, Inc. 8.2.4 Celgene Corparation 8.2.5 M’s Science Corporation 8.2.6 Mitsubishi Results:  First -   Prev -   1 -   Next -   Last

		For enquiries please call us on:   +353-1-415-1241 (GMT Office Hours)   1-800-526-8630 (US/Canada Toll Free)   1-917-300-0470 (EST Office Hours)

All rights reserved. © Copyright 2012 Research and Markets3    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network